Table 2 Patient demographic, clinical, and operative data
Characteristic | NACT (n=52) | Non-NACT (n=271) | P | |
|---|---|---|---|---|
Age | 64.35±5.77 | 63.59±8.54 | 0.542 | |
Sex† | Male | 45 (86.5) | 222 (81.9) | 0.420 |
Female | 7 (13.5) | 49 (18.1) | ||
Smoking† | Yes | 35 (67.3) | 165 (60.9) | 0.382 |
No | 17 (32.7) | 106 (39.1) | ||
Drinking† | Yes | 34 (65.4) | 155 (57.2) | 0.272 |
No | 18 (34.6) | 116 (42.8) | ||
Comorbidity† | 26 (50.0) | 124 (45.8) | 0.574 | |
KPS | 80.77±8.37 | 80.37±6.31 | 0.693 | |
PNI | 48.30±4.51 | 51.21±5.01 | <.001** | |
ASA status† | I | 4 (7.7) | 39 (14.4) | 0.264 |
II | 40 (76.9) | 205 (75.6) | ||
III | 8 (15.4) | 27 (10.0) | ||
Lymphadenectomy† | 2D | 5 (9.6) | 35 (12.9) | 0.508 |
2D+ | 47 (90.4) | 236 (87.1) | ||
Operation duration | 224.10±29.58 | 210.76±29.21 | 0.003** | |
Estimated blood loss | 121.73±33.65 | 111.88±42.56 | 0.116 | |
Tumor location†‡ | Upper | 11 (21.2) | 45 (16.6) | 0.439 |
Middle | 20 (38.5) | 111 (41.0) | ||
Lower | 11 (21.2) | 81 (29.9) | ||
Upper and middle | 5 (9.6) | 21 (7.7) | ||
Middle and lower | 5 (9.6) | 13 (4.8) | ||